Page last updated: 2024-10-16

choline and Osteosarcoma

choline has been researched along with Osteosarcoma in 5 studies

Osteosarcoma: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lamego, I2
Duarte, IF2
Marques, MP2
Gil, AM2
Marques, J1
Blaise, BJ1
Gosling, M1
Smith, JW1
Poyner, DR1
Li, YP1
Baskin, F1
Davis, R1
Hersh, LB1
Singh, AT1
Radeff, JM1
Kunnel, JG1
Stern, PH1

Other Studies

5 other studies available for choline and Osteosarcoma

ArticleYear
Metabolic markers of MG-63 osteosarcoma cell line response to doxorubicin and methotrexate treatment: comparison to cisplatin.
    Journal of proteome research, 2014, Dec-05, Volume: 13, Issue:12

    Topics: Amino Acids; Antineoplastic Agents; Biomarkers, Tumor; Cell Line, Tumor; Cell Membrane; Choline; Cis

2014
Nuclear magnetic resonance (NMR) study of the effect of cisplatin on the metabolic profile of MG-63 osteosarcoma cells.
    Journal of proteome research, 2010, Nov-05, Volume: 9, Issue:11

    Topics: Alcohols; Amino Acids; Choline; Cisplatin; Humans; Kinetics; Lipids; Magnetic Resonance Spectroscopy

2010
Characterization of a volume-sensitive chloride current in rat osteoblast-like (ROS 17/2.8) cells.
    The Journal of physiology, 1995, Jun-15, Volume: 485 ( Pt 3)

    Topics: Animals; Calcium; Calcium Channel Blockers; Cell Membrane Permeability; Chloride Channels; Choline;

1995
Cholinergic neuron-specific expression of the human choline acetyltransferase gene is controlled by silencer elements.
    Journal of neurochemistry, 1993, Volume: 61, Issue:2

    Topics: Animals; Choline; Choline O-Acetyltransferase; Gene Expression Regulation; Humans; Neuroblastoma; Ne

1993
Phosphatidylcholine-specific phospholipase C inhibitor, tricyclodecan-9-yl xanthogenate (D609), increases phospholipase D-mediated phosphatidylcholine hydrolysis in UMR-106 osteoblastic osteosarcoma cells.
    Biochimica et biophysica acta, 2000, Sep-27, Volume: 1487, Issue:2-3

    Topics: Antineoplastic Agents; Bone Neoplasms; Bridged-Ring Compounds; Choline; Down-Regulation; Drug Synerg

2000